Search Orphan Drug Designations and Approvals
-
Generic Name: | Indolino-benzodiazepine compound (sulfonated DGN549-C) conjugated to the humanized anti-CD123 monoclonal antibody (G4723A) |
---|---|
Date Designated: | 11/17/2020 |
Orphan Designation: | Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ImmunoGen, Inc. 830 Winter Street Waltham, Massachusetts 02451 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-